Quantcast

Latest Spinal cord stimulator Stories

2014-06-25 23:11:56

Transparency Market Research published a new report "Global Neuromodulation Devices Market: Size, Share, Trends, Analysis and Forecast 2012 - 2018" to its report store. Browse the full report: http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html. Albany, New York (PRWEB) June 25, 2014 This report covers an in depth analysis of the neuromodulation devices market across the globe. A detailed analysis of the market size in terms of annual revenue in...

2014-05-30 23:08:39

GrandViewResearch.com has announced the addition of "Global Neurostimulation Devices Market Analysis And Segment Forecasts To 2020" Market Research report to their Database. View full report With TOC - http://www.grandviewresearch.com/industry-analysis/neurostimulation-devices-industry. San Francisco, California (PRWEB) May 30, 2014 The global market for neurostimulation devices is expected to reach USD 8,791.8 million by 2020, according to a new study by Grand View Research,...

2014-05-08 04:21:45

Advanced Illumina(TM) 3D Programming Software Provides Highly Significant Pain Relief in Study Patients NATICK, Mass., May 8, 2014 /PRNewswire/ -- New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra(TM) Spinal Cord Stimulator (SCS) System demonstrate the device provided sustained and highly significant relief of low-back pain six months after implantation. Results were presented at the World Institute of Pain (WIP) 7(th) World Congress in...

2014-05-07 23:12:57

Newly-approved device is the world’s first and only neurostimulator that is upgradeable and able to access new features once approved without additional surgery. Southlake, Texas (PRWEB) May 07, 2014 This month, Amit Darnule, M.D., became the first physician in the Greater Fort Worth area to implant the Protégé™ IPG, the world’s first and only neurostimulation system that allows technology upgrades as they are approved to be made via software updates. With this device,...

2014-05-05 12:29:04

In the news release, U.S. Market for Neurostimulation Devices Will Reach Almost $4 Billion by 2022, issued 09-Apr-2014 by Decision Resources Group over PR Newswire, we are advised by the company that the first paragraph, second sentence, should read "NeuroPace's responsive stimulation device" rather than "NeuroPace's deep brain stimulation (DBS) device" as originally issued. The complete, corrected release follows: U.S. Market for Neurostimulation Devices Will Reach Almost $4 Billion by...

2014-04-11 08:24:20

DUBLIN, April. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kjxvb2/nerve_repair_and ) has announced the addition of the "Nerve Repair & Regeneration Market by Xenografts, Neuromodulation, External & Surgery - Global Trend & Forecast to 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) This report categorizes the market into the peripheral nerve repair segment and the neuromodulation segment....

2014-04-09 12:31:15

New Indications and Demand for Replacement Devices Will Drive Market Expansion, According to Findings from Decision Resources Group BURLINGTON, Mass., April 9, 2014 /PRNewswire/ -- Decision Resources Group finds that the approval of new indications--particularly chronic heart failure, obesity and epilepsy--will expand the patient pool and market potential for neurostimulation devices in the United States considerably, allowing the market to reach a value approaching $4 billion by 2022. Most...

2014-03-31 08:28:22

MENLO PARK, Calif., March 31, 2014 /PRNewswire/ -- Nevro, a growth stage medical device company focused on developing innovative, evidence based solutions in the neuromodulation space, announced today the appointment of Dr. David Caraway as its Chief Medical Officer. Dr. Caraway will provide strategic direction and support the design, development, and adoption of cutting-edge therapies that aim to advance the neuromodulation field. He will also represent Nevro's mission and values in...

2014-03-26 04:21:03

PARIS, March 25, 2014 /PRNewswire/ -- Pixium Vision ("Pixium"), a developer of innovative Vision Restoration Systems for the blind, today announces the appointment of Khalid Ishaque as Chief Executive Officer and Director. Mr Ishaque joins from Boston Scientific, and brings over 22 years of management experience in the medical technology industry. Mr Ishaque spent 17 years with Boston Scientific Corporation, where most recently he was General Manager of its...

2014-03-20 23:22:31

Capitol Pain Institute's founder recently presented a seminar at one of the most influential fellows programs in the country. Austin, TX (PRWEB) March 20, 2014 For all medical products and services, risk management over the years has become a very important issue, and thanks to the seminar Dr. Matthew Schocket presented at the St. Jude Medical National Neuromodulation 201 Fellows Program, pain fellows now have a clear-cut strategy on reducing risk in their practices and keeping...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related